Reporting of Suspected Adverse Events

Reporting of Suspected Adverse Events

Adverse Events should be reported.

An adverse event about a LEO Pharma product in Finland can be reported directly via the national reporting system, see https://www.fimea.fi/laaketurvallisuus_ja_tieto/laakkeiden_turvallisuus/haittavaikutuksista_ilmoittaminen

You can also contact LEO Pharma directly via e-mail: nordic_drugsafety@leo-pharma.com